Close Menu

NEW YORK (GenomeWeb) – Pharmacogenetics firm Geneticure last week began selling a test for personalizing treatments for high blood pressure via a consumer-facing online model.

However, the company is also pursuing a prospective, randomized controlled trial to demonstrate the safety and efficacy of its test compared to the standard methods of prescribing blood pressure medications. Geneticure plans to submit data from this study to the US Food and Drug Administration for regulatory approval of its test.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.